Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid and Synbiotic plus phototherapy vs phototherapy alone in neonatal indirect hyperbilirubinemia
IRCT20181006041252N9Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ursodeoxycholic acid in neonatal hyperbilirubinemia (2 arms), sponsored by Sabzevar University of Medical Sciences. Started Jan 2019; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on IRCT20181006041252N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181006041252N9.